Doxorubicin/ifosfamide/mesnaLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72627-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：190 / 190

相关论文

共 50 条

[1] Doxorubicin/ifosfamide/mesnaLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 198 - 198
[2] Doxorubicin/ifosfamide/mesnaLack of efficacy : case report
Reactions Weekly, 2023, 1949 (1) : 187 - 187
[3] Epirubicin/ifosfamide/mesnaLack of efficacy: case report
Reactions Weekly, 2022, 1928 (1) : 173 - 173
[4] Doxorubicin/ifosfamide/selumetinibLack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 182 - 182
[5] Doxorubicin/ifosfamide/pazopanibLack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 115 - 115
[6] Doxorubicin/ifosfamide/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 200 - 200
[7] Doxorubicin/ifosfamide/pazopanibLack of efficacy: case report
Reactions Weekly, 2025, 2052 (1) : 158 - 158
[8] Doxorubicin/ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 171 - 171
[9] Doxorubicin/ifosfamide/lenvatinibHaemoperitoneum and lack of efficacy : case report
Reactions Weekly, 2025, 2049 (1) : 140 - 140
[10] Antineoplastics/mesnaLack of efficacy: case report
Reactions Weekly, 2022, 1902 (1) : 67 - 67

← 1 2 3 4 5 →